Furthermore, it is revealed that in HNSCC xenograft mouse models constructed with cisplatin-resistant cell line, Iacs-eif3c-RNA demonstrated superior anti-tumor efficacy and remarkable biosafety compared to cisplatin. This evidence concerns the gene EIF3C and neoplasm.